Serum Tryptase Levels in Patients with Mastocytosis: Correlation with Mast Cell Burden and Implication for Defining the Category of Disease

Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Hsu, S. M., Raine, L., & Fanger, H. (1981) · Journal of Histochemistry & Cytochemistry · doi:10.1177/29.4.6166661 · Cited by 14,075

Changing patterns in the incidence of esophageal and gastric carcinoma in the United States

Devesa, S. S., Blot, W. J., & Fraumeni, J. F. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19981115)83:10 · Cited by 2,097

Diagnostic criteria and classification of mastocytosis: a consensus proposal

Valent, P., Horny, H., Escribano, L., Longley, B. J., Li, C. Y., Schwartz, L. B., Marone, G., Núñez, R., Akin, C., Sotlar, K., et al. (2001) · Leukemia Research · doi:10.1016/s0145-2126(01)00038-8 · Cited by 1,114

Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder.

Nagata, H., Worobec, A. S., Oh, C. K., Chowdhury, B. A., Tannenbaum, S. H., Suzuki, Y., & Metcalfe, D. D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10560 · Cited by 871

Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis

Schwartz, L. B., Metcalfe, D. D., Miller, J. S., Earl, H., & Sullivan, T. (1987) · New England Journal of Medicine · doi:10.1056/nejm198706253162603 · Cited by 784

Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm

Longley, B. J., Tyrrell, L., Lu, S.-Z., Ma, Y., Langley, K., Ding, T.-G., Duffy, T. P., Jacobs, P., Tang, L. H., & Modlin, I. M. (1996) · Nature Genetics · doi:10.1038/ng0396-312 · Cited by 606

Activating and dominant inactivating c- KIT catalytic domain mutations in distinct clinical forms of human mastocytosis

Longley, B. J., Metcalfe, D. D., Tharp, M. D., Wang, X., Tyrrell, L., Lu, S.-Z., Heitjan, D., & Ma, Y. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1609 · Cited by 550

Systemic Mast Cell Disease

Travis, W. D., Li, C., Bergstralh, E. J., Yam, L. T., & Swee, R. G. (1988) · Medicine · doi:10.1097/00005792-198811000-00001 · Cited by 485

The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis.

Schwartz, L. B., Sakai, K., Bradford, T. R., Ren, S., Zweiman, B., Worobec, A. S., & Metcalfe, D. D. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118337 · Cited by 371

Classification and Diagnosis of Mastocytosis: Current Status

Metcalfe, D. D. (1991) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12468882 · Cited by 344

Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria

Valent, P., Akin, C., Escribano, L., Födinger, M., Hartmann, K., Brockow, K., Castells, M., Sperr, W. R., Kluin‐Nelemans, H. C., Hamdy, N. A. T., et al. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01807.x · Cited by 750

Diagnostic Value of Tryptase in Anaphylaxis and Mastocytosis

Schwartz, L. B. (2006) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2006.05.010 · Cited by 477

Anaphylaxis—a practice parameter update 2015

Lieberman, P., Nicklas, R. A., Randolph, C., Oppenheimer, J., Bernstein, D., Bernstein, J., Ellis, A., Golden, D. B. K., Greenberger, P., Kemp, S., et al. (2015) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2015.07.019 · Cited by 474

Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels

Bonadonna, P., Perbellini, O., Passalacqua, G., Caruso, B., Colarossi, S., Dal Fior, D., Castellani, L., Bonetto, C., Frattini, F., Dama, A., et al. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.11.018 · Cited by 392

Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal

Valent, P., Akin, C., Hartmann, K., Alvarez-Twose, I., Brockow, K., Hermine, O., Niedoszytko, M., Schwaab, J., Lyons, J. J., Carter, M. C., et al. (2021) · HemaSphere · doi:10.1097/hs9.0000000000000646 · Cited by 317

Mastocytosis: State of the Art

Horny, H.-P., Sotlar, K., & Valent, P. (2007) · Pathobiology · doi:10.1159/000101711 · Cited by 225

Diagnosis and treatment of systemic mastocytosis: state of the art

Valent, P., Akin, C., Sperr, W. R., Horny, H., Arock, M., Lechner, K., Bennett, J. M., & Metcalfe, D. D. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04575.x · Cited by 210

Mastocytosis: Pathology, genetics, and current options for therapy

Valent, P., Akin, C., Sperr, W. R., Mayerhofer, M., Födinger, M., Fritsche‐Polanz, R., Sotlar, K., Escribano, L., Arock, M., Horny, H., et al. (2004) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190400010775 · Cited by 196

Hereditary α tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis

Greiner, G., Sprinzl, B., Górska, A., Ratzinger, F., Gurbisz, M., Witzeneder, N., Schmetterer, K. G., Gisslinger, B., Uyanik, G., Hadzijusufovic, E., et al. (2021) · Blood · doi:10.1182/blood.2020006157 · Cited by 189

Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non–mast cell hematopoietic neoplasms

Valent, P., Sperr, W. R., Schwartz, L. B., & Horny, H. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.02.045 · Cited by 164

Pathogenesis, classification and treatment of mastocytosis: state of the art in 2010 and future perspectives

Arock, M., & Valent, P. (2010) · Expert Review of Hematology · doi:10.1586/ehm.10.42 · Cited by 163

Why the 20% + 2 Tryptase Formula Is a Diagnostic Gold Standard for Severe Systemic Mast Cell Activation and Mast Cell Activation Syndrome

Valent, P., Bonadonna, P., Hartmann, K., Broesby-Olsen, S., Brockow, K., Butterfield, J. H., Triggiani, M., Lyons, J. J., Oude Elberink, J. N. G., Arock, M., et al. (2019) · International Archives of Allergy and Immunology · doi:10.1159/000501079 · Cited by 146

International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study

Sperr, W. R., Kundi, M., Álvarez‐Twöse, I., van Anrooij, B., Elberink, J. N. G. O., Górska, A., Niedoszytko, M., Gleixner, K. V., Hadzijusufovic, E., Zanotti, R., et al. (2019) · The Lancet Haematology · doi:10.1016/s2352-3026(19)30166-8 · Cited by 144

Response to therapy with interferon alpha-2b and prednisolone in aggressive systemic mastocytosis: report of five cases and review of the literature

Hauswirth, A. W., Simonitsch‐Klupp, I., Uffmann, M., Koller, E., Sperr, W. R., Lechner, K., & Valent, P. (2003) · Leukemia Research · doi:10.1016/s0145-2126(03)00259-5 · Cited by 142

Diagnostic and subdiagnostic accumulation of mast cells in the bone marrow of patients with anaphylaxis: monoclonal mast cell activation syndrome

Sonneck, K., Florian, S., Müllauer, L., Wimazal, F., Födinger, M., Sperr, W. R., & Valent, P. (2007) · International Archives of Allergy and Immunology · doi:10.1159/000096442 · Cited by 129

Diagnostic Criteria and Classification of Mastocytosis in 2014

Akin, C., & Valent, P. (2014) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2014.02.003 · Cited by 124

Mast Cells as Key Players in Allergy and Inflammation

González‐de‐Olano, D., & Álvarez‐Twöse, I. (2018) · Journal of Investigational Allergology and Clinical Immunology · doi:10.18176/jiaci.0327 · Cited by 122

Systemic Mastocytosis, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

Gotlib, J., Gerds, A. T., Bose, P., Castells, M. C., Deininger, M. W., Gojo, I., Gundabolu, K., Hobbs, G., Jamieson, C., McMahon, B., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0088 · Cited by 106

The KIT D 816 V allele burden predicts survival in patients with mastocytosis and correlates with the WHO type of the disease

Hoermann, G., Gleixner, K. V., Dinu, G. E., Kundi, M., Greiner, G., Wimazal, F., Hadzijusufovic, E., Mitterbauer, G., Mannhalter, C., Valent, P., et al. (2014) · Allergy · doi:10.1111/all.12409 · Cited by 106

Assessment of clinical findings, tryptase levels, and bone marrow histopathology in the management of pediatric mastocytosis

Carter, M. C., Clayton, S. T., Komarow, H. D., Brittain, E., Scott, L. M., Cantave, D., Gaskins, D., Marić, I., & Metcalfe, D. D. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.04.024 · Cited by 104

Clinical aspects of paediatric mastocytosis: a review of 101 cases

Lange, M., Niedoszytko, M., Renke, J., Gleń, J., & Nedoszytko, B. (2011) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2011.04365.x · Cited by 100

Evaluation of the WHO criteria for the classification of patients with mastocytosis

Sánchez‐Muñoz, L., Álvarez‐Twöse, I., García‐Montero, A. C., Teodósio, C., Jara‐Acevedo, M., Pedreira, C. E., Matito, A., Morgado, J. M., Sánchez, M. L., Mollejo, M., et al. (2011) · Modern Pathology · doi:10.1038/modpathol.2011.84 · Cited by 99

Consensus Opinion on Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis

Üstün, C., Gotlib, J. R., Popat, U., Artz, A. S., Litzow, M. R., Reiter, A., Nakamura, R., Kluin‐Nelemans, H. C., Verstovšek, S., Gajewski, J., et al. (2016) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2016.04.018 · Cited by 103

Elevated tryptase levels selectively cluster in myeloid neoplasms: a novel diagnostic approach and screen marker in clinical haematology

Sperr, W. R., El‐Samahi, A., Kundi, M., Girschikofsky, M., Winkler, S., Lutz, D., Endler, G., Rumpold, H., Agis, H., Sillaber, C., et al. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02184.x · Cited by 98

Large maculopapular cutaneous lesions are associated with favorable outcome in childhood-onset mastocytosis

Wiechers, T., Rabenhorst, A., Schick, T., Preußner, L., Förster, A., Valent, P., Horny, H., Sotlar, K., & Hartmann, K. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.05.034 · Cited by 84

The serum tryptase test: an emerging robust biomarker in clinical hematology

Valent, P., Sperr, W. R., Sotlar, K., Reiter, A., Akin, C., Gotlib, J., Horny, H.-P., & Arock, M. (2014) · Expert Review of Hematology · doi:10.1586/17474086.2014.955008 · Cited by 83

Unique Effects of KIT D816V in BaF3 Cells: Induction of Cluster Formation, Histamine Synthesis, and Early Mast Cell Differentiation Antigens

Mayerhofer, M., Gleixner, K. V., Hoelbl‐Kovacic, A., Florian, S., Hoermann, G., Aichberger, K. J., Bilban, M., Esterbauer, H., Krauth, M., Sperr, W. R., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.8.5466 · Cited by 85

Dermoscopic Features of Skin Lesions in Patients With Mastocytosis

Vañó-Galván, S. (2011) · Archives of Dermatology · doi:10.1001/archdermatol.2011.190 · Cited by 80

Indolent Systemic Mastocytosis with Elevated Serum Tryptase, Absence of Skin Lesions, and Recurrent Severe Anaphylactoid Episodes

Florian, S., Krauth, M., Simonitsch‐Klupp, I., Sperr, W. R., Fritsche‐Polanz, R., Sonneck, K., Födinger, M., Agis, H., Böhm, A., Wimazal, F., et al. (2005) · International Archives of Allergy and Immunology · doi:10.1159/000083954 · Cited by 80

Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification

Trizuljak, J., Sperr, W. R., Nekvindová, L., Elberink, H. O., Gleixner, K. V., Górska, A., Lange, M., Hartmann, K., Illerhaus, A., Bonifacio, M., et al. (2020) · Allergy · doi:10.1111/all.14248 · Cited by 80

Severe Life-Threatening or Disabling Anaphylaxis in Patients with Systemic Mastocytosis: A Single-Center Experience

Wimazal, F., Geißler, P., Shnawa, P., Sperr, W. R., & Valent, P. (2011) · International Archives of Allergy and Immunology · doi:10.1159/000329218 · Cited by 75

The Genetic Basis and Clinical Impact of Hereditary Alpha-Tryptasemia

Luskin, K. T., White, A. A., & Lyons, J. J. (2021) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2021.03.005 · Cited by 69

Mast cell proliferative disorders: current view on variants recognized by the World Health Organization

Valent, P., Akin, C., Sperr, W. R., Horny, H.-P., & Metcalfe, D. D. (2003) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(03)00089-3 · Cited by 65

Cutaneous Mastocytosis in Adults and Children

Matito, A., Defez, J. M. A., Torrelo, A., & Álvarez‐Twöse, I. (2018) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2018.04.001 · Cited by 67

Cutaneous manifestations in Hymenoptera and Diptera anaphylaxis: relationship with basal serum tryptase

Potier, A., Lavigne, C., Chappard, D., Verret, J. L., Chevailler, A., Nicolie, B., & Drouet, M. (2009) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2009.03210.x · Cited by 64

How we diagnose and treat systemic mastocytosis in adults

Scherber, R. M., & Borate, U. (2017) · British Journal of Haematology · doi:10.1111/bjh.14967 · Cited by 65

IL-5 receptor α levels in patients with marked eosinophilia or mastocytosis

Wilson, T. M., Marić, I., Shukla, J., Brown, M. R., Santos, C. S., Šimáková, O., Khoury, P., Fay, M. P., Kozhich, A. T., Kolbeck, R., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.05.032 · Cited by 61

Midostaurin improves quality of life and mediator-related symptoms in advanced systemic mastocytosis

Hartmann, K., Gotlib, J. R., Akin, C., Hermine, O., Awan, F. T., Hexner, E. O., Mauro, M. J., Menssen, H. D., Redhu, S., Knoll, S., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.03.044 · Cited by 60

Pathogenesis and Pathology of Mastocytosis

Metcalfe, D. D., & Mekori, Y. A. (2017) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-052016-100312 · Cited by 60

Proposed diagnostic criteria and classification of basophilic leukemias and related disorders

Valent, P., Sotlar, K., Blatt, K., Hartmann, K., Reiter, A., Sadovnik, I., Sperr, W. R., Bettelheim, P., Akin, C., Bauer, K., et al. (2017) · Leukemia · doi:10.1038/leu.2017.15 · Cited by 59

Refined diagnostic criteria for bone marrow mastocytosis: a proposal of the European competence network on mastocytosis

Zanotti, R., Bonifacio, M., Lucchini, G., Sperr, W. R., Scaffidi, L., van Anrooij, B., Oude Elberink, H. N., Rossignol, J., Hermine, O., Gorska, A., et al. (2022) · Leukemia · doi:10.1038/s41375-021-01406-y · Cited by 56

Childhood mastocytosis

Torrelo, A., Álvarez‐Twöse, I., & Escribano, L. (2012) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e328355b248 · Cited by 57

Serum tryptase correlates with the KIT D816V mutation burden in adults with indolent systemic mastocytosis

Kristensen, T. K., Broesby‐Olsen, S., Vestergaard, H., Bindslev‐Jensen, C., & Møller, M. B. (2013) · European Journal Of Haematology · doi:10.1111/ejh.12128 · Cited by 55

Long-term treatment with imatinib results in profound mast cell deficiency in Ph+ chronic myeloid leukemia

Cerny‐Reiterer, S., Rabenhorst, A., Stefanzl, G., Herndlhofer, S., Hoermann, G., Müllauer, L., Baumgartner, S., Beham‐Schmid, C., Sperr, W. R., Mannhalter, C., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.3074 · Cited by 59

Myeloid/Lymphoid Neoplasms with Eosinophilia and TK Fusion Genes, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology

Gerds, A. T., Gotlib, J. R., Bose, P., Deininger, M. W., Dunbar, A. J., Elshoury, A., George, T. I., Gojo, I., Gundabolu, K., Hexner, E. O., et al. (2020) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2020.0042 · Cited by 55

Anesthesia in children with mastocytosis – a case based review

AHMAD, N. S., Evans, P., & Lloyd-Thomas, A. R. (2009) · Pediatric Anesthesia · doi:10.1111/j.1460-9592.2008.02904.x · Cited by 54

Massive release of the histamine‐degrading enzyme diamine oxidase during severe anaphylaxis in mastocytosis patients

Boehm, T., Reiter, B., Ristl, R., Petroczi, K., Sperr, W., Stimpfl, T., Valent, P., & Jilma, B. (2019) · Allergy · doi:10.1111/all.13663 · Cited by 53

Mastocytosis-derived extracellular vesicles exhibit a mast cell signature, transfer KIT to stellate cells, and promote their activation

Kim, D., Cho, Y., Komarow, H. D., Bandara, G., Song, B., Olivera, A., & Metcalfe, D. D. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1809938115 · Cited by 52

Detection of KIT D816V in peripheral blood of children with manifestations of cutaneous mastocytosis suggests systemic disease

Carter, M. C., Bai, Y., Ruiz-Esteves, K. N., Scott, L. M., Cantave, D., Bolan, H., Eisch, R. A., Sun, X., Hahn, J., Marić, I., et al. (2018) · British Journal of Haematology · doi:10.1111/bjh.15624 · Cited by 52

Genetic Regulation of Tryptase Production and Clinical Impact: Hereditary Alpha Tryptasemia, Mastocytosis and Beyond

Sprinzl, B., Greiner, G., Uyanik, G., Arock, M., Haferlach, T., Sperr, W. R., Valent, P., & Hoermann, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052458 · Cited by 51

Clinical and laboratory parameters of mast cell activation as basis for the formulation of diagnostic criteria

Valent, P., Horny, H.-P., Triggiani, M., & Arock, M. (2011) · International Archives of Allergy and Immunology · doi:10.1159/000323763 · Cited by 50

Diagnostic Evaluation and Classification of Mastocytosis

Valent, P. (2006) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2006.05.002 · Cited by 50

Mast cell mediators of significance in clinical practice in mastocytosis

Butterfield, J. H., Ravi, A., & Pongdee, T. (2018) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2018.04.011 · Cited by 48

Incorporating Tryptase Genotyping Into the Workup and Diagnosis of Mast Cell Diseases and Reactions

Lyons, J. J., Greiner, G., Hoermann, G., & Metcalfe, D. D. (2022) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2022.05.003 · Cited by 50

Current approaches to the diagnosis and treatment of systemic mastocytosis

Bains, S. N., & Hsieh, F. H. (2010) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2009.11.006 · Cited by 47

Risk factors and management of severe life‐threatening anaphylaxis in patients with clonal mast cell disorders

Valent, P. (2014) · Clinical & Experimental Allergy · doi:10.1111/cea.12318 · Cited by 47

Urticaria pigmentosa

Brockow, K. (2004) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2004.01.002 · Cited by 49

Prevalence and risk factors for fragility fracture in systemic mastocytosis

Degboé, Y., Eischen, M., Nigon, D., Apoil, P.-A., Mailhol, C., Tournier, E., Laurent, C., Hanssens, K., Hermine, O., Paul, C., et al. (2017) · Bone · doi:10.1016/j.bone.2017.09.005 · Cited by 44

Mastocytosis

Horny, H. (2009) · American Journal of Clinical Pathology · doi:10.1309/ajcppxhmn5cjoxhz · Cited by 44

Systemic mastocytosis: a rare cause of osteoporosis and its response to bisphosphonate treatment

Lim, A. Y. N., Östör, A. J. K., Love, S., & Crisp, A. J. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.029116 · Cited by 44

Systemic Mastocytosis: Clinical Manifestations and Differential Diagnosis

Butterfield, J. H. (2006) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2006.05.006 · Cited by 45

Uncommon phenotypes of acute myelogenous leukemia: Basophilic, mast cell, eosinophilic, and myeloid dendritic cell subtypes: A review

Lichtman, M. A., & Segel, G. B. (2005) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2005.08.006 · Cited by 40

Diagnosis, progression patterns and prognostication in mastocytosis

Sperr, W. R., & Valent, P. (2012) · Expert Review of Hematology · doi:10.1586/ehm.12.12 · Cited by 42

Systemic Mastocytosis

Robyn, J. A., & Metcalfe, D. D. (2006) · Advances in immunology · doi:10.1016/s0065-2776(05)89005-4 · Cited by 38

Clinical impact of the TPSAB1 genotype in mast cell diseases: A REMA study in a cohort of 959 individuals

González‐de‐Olano, D., Navarro‐Navarro, P., Muñoz‐González, J. I., Sánchez‐Muñoz, L., Henriques, A., de‐Andrés‐Martín, A., Peralta‐Arjonilla, D., Mayado, A., Jara‐Acevedo, M., García‐Montero, A. C., et al. (2024) · Allergy · doi:10.1111/all.15911 · Cited by 38

Multidisciplinary Management of Mastocytosis: Nordic Expert Group Consensus

Broesby‐Olsen, S., Dybedal, I., Gülen, T., Kristensen, T. K., Møller, M. B., Ackermann, L., Sääf, M., Karlsson, M., Agertoft, L., Brixen, K., et al. (2015) · Acta Dermato Venereologica · doi:10.2340/00015555-2325 · Cited by 40

Gastrointestinal Manifestations in Systemic Mastocytosis: The Need of a Multidisciplinary Approach

Zanelli, M., Pizzi, M., Sanguedolce, F., Zizzo, M., Palicelli, A., Soriano, A., Bisagni, A., Martino, G., Caprera, C., Moretti, M., et al. (2021) · Cancers · doi:10.3390/cancers13133316 · Cited by 39

Elevated Serum Tryptase in Non-Anaphylaxis Cases: A Concise Review

Lee, A. Y. S. (2020) · International Archives of Allergy and Immunology · doi:10.1159/000506199 · Cited by 36

World Health Organization Classification and Diagnosis of Mastocytosis

Valent, P., Sotlar, K., Horny, H., Arock, M., & Akin, C. (2023) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2023.04.011 · Cited by 37

Serum Tryptase Monitoring in Indolent Systemic Mastocytosis: Association with Disease Features and Patient Outcome

Matito, A., Morgado, J. M., Álvarez‐Twöse, I., Sánchez‐Muñoz, L., Pedreira, C. E., Jara‐Acevedo, M., Teodósio, C., Sánchez-López, P., Fernández-Núñez, E., Moreno-Borque, R., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076116 · Cited by 37

Eosinophilic Myeloproliferative Disorders

Klion, A. D. (2011) · Hematology · doi:10.1182/asheducation-2011.1.257 · Cited by 36

Differential diagnosis of chronic urticaria

Brodell, L. A., & Beck, L. A. (2008) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)60438-3 · Cited by 35

Comparative oncology: The paradigmatic example of canine and human mast cell neoplasms

Willmann, M., Hadzijusufovic, E., Hermine, O., Dacasto, M., Marconato, L., Bauer, K., Peter, B., Gamperl, S., Eisenwort, G., Jensen‐Jarolim, E., et al. (2018) · Veterinary and Comparative Oncology · doi:10.1111/vco.12440 · Cited by 40

Recurrent syncope and anaphylaxis as presentation of systemic mastocytosis in a pediatric patient: Case report and literature review

Shaffer, H. C., Parsons, D. J., Peden, D. B., & Morrell, D. S. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2005.06.012 · Cited by 32

Peripheral ulcerative keratitis in rheumatoid arthritis: successful use of intravenous cyclophosphamide and comparison of clinical and serological characteristics

Clewes, A., Dawson, J. K., Kaye, S., & Bucknall, R. C. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.023283 · Cited by 31

Determination of Plasma Heparin Level Improves Identification of Systemic Mast Cell Activation Disease

Vysniauskaite, M., Hertfelder, H.-J., Oldenburg, J., Dreßen, P., Brettner, S., Homann, J., & Molderings, G. J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0124912 · Cited by 30

Mast cell activation in the context of elevated basal serum tryptase: genetics and presentations

Khoury, P., & Lyons, J. J. (2019) · Current Allergy and Asthma Reports · doi:10.1007/s11882-019-0887-x · Cited by 30

Scoring the Risk of Having Systemic Mastocytosis in Adult Patients with Mastocytosis in the Skin

Fuchs, D., Kilbertus, A., Kofler, K., von Bubnoff, N., Shoumariyeh, K., Zanotti, R., Bonadonna, P., Scaffidi, L., Doubek, M., Elberink, H. O., et al. (2021) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2020.12.022 · Cited by 30

Serum concentration of baseline mast cell tryptase: evidence for a decline during long‐term immunotherapy for Hymenoptera venom allergy

Dugas‐Breit, S., Przybilla, B., Dugas, M., Arnold, A. J., Pfundstein, G., Küchenhoff, H., & Ruëff, F. (2010) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2009.03436.x · Cited by 30

Mastocytosis

Akin, C., Arock, M., Carter, M. C., George, T. I., & Valent, P. (2025) · Nature Reviews Disease Primers · doi:10.1038/s41572-025-00611-8 · Cited by 31

Urinary 11β‐PGF 2α and N‐methyl histamine correlate with bone marrow biopsy findings in mast cell disorders

Divekar, R., & Butterfield, J. (2015) · Allergy · doi:10.1111/all.12668 · Cited by 27

Refined Treatment Response Criteria for Indolent Systemic Mastocytosis Proposed by the ECNM-AIM Consortium

Pyatilova, P., Akin, C., Alvarez-Twose, I., Arock, M., Bonadonna, P., Brockow, K., Butterfield, J. H., Broesby-Olsen, S., Carter, M. C., Castells, M., et al. (2022) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2022.05.037 · Cited by 27

New Insights into the Pathogenesis, Diagnosis, and Management of Mastocytosis

Fuller, S. J. (2012) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2012.08.008 · Cited by 27

Chronic myeloproliferative disorders

Niemeyer, C. M., & Locatelli, F. (2006) · Cambridge University Press eBooks · doi:10.1017/cbo9780511471001.023 · Cited by 27

Actualización en mastocitosis. Parte 1: fisiopatología, clínica y diagnóstico

Azaña, J. M., Torrelo, A., & Matito, A. (2015) · Actas Dermo-Sifiliográficas · doi:10.1016/j.ad.2015.09.007 · Cited by 26

Mastocytoses et anesthésie

Dewachter, P., Mouton‐Faivre, C., Cazalaà, J.-B., Carli, P. A., Lortholary, O., & Hermine, O. (2008) · Annales Françaises d Anesthésie et de Réanimation · doi:10.1016/j.annfar.2008.09.022 · Cited by 26

Current Concepts on Diagnosis and Treatment of Mastocytosis

Magliacane, D., Parente, R., & Triggiani, M. (2014) · Europe PMC (PubMed Central) · doi:10.14273/unisa-233 · Cited by 26

Untitled work

(2023) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2023.07.001 · Cited by 25

Secretory and Membrane-Associated Biomarkers of Mast Cell Activation and Proliferation

Parente, R., Giudice, V., Cardamone, C., Serio, B., Selleri, C., & Triggiani, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087071 · Cited by 26

Comparison of serum tryptase and urine N-methylhistamine in patients with suspected mastocytosis

van Toorenenbergen, A. W., & Oranje, A. P. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2005.03.041 · Cited by 25

Alpha-tryptase as a risk-modifying factor for mast cell–mediated reactions

Shin, H., & Lyons, J. J. (2024) · Current Allergy and Asthma Reports · doi:10.1007/s11882-024-01136-y · Cited by 24

Anaphylaxis and urticaria.

Williams, K. W., & Sharma, H. (2015) · Immunology and allergy clinics of North America · doi:10.1016/j.iac.2014.09.010 · Cited by 21

Actualités sur la compréhension et le traitement des mastocytoses systémiques

Georgin‐Lavialle, S., Barète, S., Suárez, F., Lepelletier, Y., Bodemer, C., Dubreuil, P. C., Lortholary, O., & Hermine, O. (2008) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2008.01.025 · Cited by 24

Bone Marrow Mastocytosis: A Diagnostic Challenge

Zanotti, R., Tanasi, I., Bernardelli, A., Orsolini, G., & Bonadonna, P. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10071420 · Cited by 24

Diagnostic Significance of Tryptase for Suspected Mast Cell Disorders

Beyens, M., Toscano, A., Ebo, D., Gülen, T., & Sabato, V. (2023) · Diagnostics · doi:10.3390/diagnostics13243662 · Cited by 22

Health-Related Quality of Life and Influencing Factors in Adults with Nonadvanced Mastocytosis—A Cross-Sectional Study and Qualitative Approach

Pulfer, S., Ziehfreund, S., Gebhard, J., Hindelang, B., Biedermann, T., Brockow, K., & Zink, A. (2021) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2021.04.059 · Cited by 24

Role of Mast Cells in the Pathogenesis of Pruritus in Mastocytosis

Kwiatkowska, D., & Reich, A. (2021) · Acta Dermato Venereologica · doi:10.2340/actadv.v101.350 · Cited by 21

Current state of biology and diagnosis of clonal mast cell diseases in adults

Álvarez‐Twöse, I., Morgado, J. M., Sánchez‐Muñoz, L., García‐Montero, A. C., Mollejo, M., Orfao, A., & ESCRIBANO, L. (2012) · International Journal of Laboratory Hematology · doi:10.1111/j.1751-553x.2012.01427.x · Cited by 21

Mast cell tryptase and carboxypeptidase A expression in body fluid and gastrointestinal tract associated with drug-related fatal anaphylaxis

Guo, X. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i47.13288 · Cited by 21

Resolving the genetics of human tryptases: implications for health, disease, and clinical use as a biomarker

O’Connell, M. P., & Lyons, J. J. (2022) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000813 · Cited by 19

Tryptase detection in bone-marrow blood: A new diagnostic tool in systemic mastocytosis

Proelss, J., Wenzel, J., Ko, Y. D., Bieber, T. R. M., & Bauer, R. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.09.020 · Cited by 16

Bone marrow tryptase as a possible diagnostic criterion for adult systemic mastocytosis

Livideanu, C. B., Apoil, P. A., Lepage, B., Eischen, M., Laurent, C., Laharrague, P. F., Lamant, L., Tournier, É., Tavitian, S., Pouplard, C., et al. (2015) · Clinical & Experimental Allergy · doi:10.1111/cea.12627 · Cited by 12

Tryptase levels in children with cutaneous mastocytosis: a prospective study

Kasikhina, E. I. (2024) · Russian Journal of Allergy · doi:10.36691/rja16963 · Cited by 1

Disease spectrum in patients with elevated serum tryptase levels

Aberer, E., SAVIC, S. L., Bretterklieber, A., Reiter, H., Berghold, A., & Aberer, W. (2014) · Australasian Journal of Dermatology · doi:10.1111/ajd.12146 · Cited by 22

Mast Cell Burden in a Patient With Cutaneous Disease

Awosika, O., Eleryan, M. G., Rengifo‐Pardo, M., & Ehrlich, A. (2017) · PubMed